Work

Pos1143 Urinary Cd163 Predicts Complete Renal Response With Zetomipzomib Treatment in the Open-label Mission Phase 2 Study in Patients With Lupus Nephritis

Year: 2023

Type: article

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2023-eular.2695

Authors: J.T. Merrill, R. Leff, A. Fan, K. Palaniswamy, N. Henig, S. Hua

Institution: Oklahoma Medical Research Foundation

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4379649977

FWCI:

Cites:

Cited by:

Related to: 10